Identification of potential biomarkers for giant cell tumor of bone using comparative proteomics analysis

American Journal of Pathology

Volumn 178, Issue 1, 2011, Pages 88-97

  Conti, Amalia ^a   Rodriguez, Gemma Caballero ^b   Chiechi, Antonella ^a   Blazquez, Rosa Maria Dégano ^b   Barbado, Victoria ^b   Krènacs, Tibor ^c   Novello, Chiara ^a   Pazzaglia, Laura ^a   Quattrini, Irene ^a   Zanella, Licciana ^a   Picci, Piero ^a   De Alava, Enrique ^b   Benassi, Maria Serena ^a  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^b CSIC   (Spain)

^c SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGRAFT INFLAMMATORY FACTOR 1; APOLIPOPROTEIN A1; COFILIN 1; GLUTATHIONE PEROXIDASE 1; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEAT SHOCK PROTEIN 27; PROTEIN CDC42; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; THIOREDOXIN PEROXIDASE; UBIQUITIN CONJUGATING ENZYME E2;

ADULT; AGED; APOPTOSIS; ARTICLE; BONE RESECTION; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; COHORT ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; FUNCTIONAL PROTEOMICS; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNODETECTION; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; OSTEOCLASTOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TISSUE MICROARRAY; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

EID: 79251470118     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2010.11.035     Document Type: Article

References (50)

1. Campanacci M: Giant cell tumor of bone. Curr Orthop 1993, 7:26-35
2. Lau YS, Sabokbar A, Gibbone CL, Giele H, Athanasou N: Phenotypic and molecular studies of giant cell tumors of bone and soft tissue. Hum Pathol 2005, 36:945-954 (Pubitemid 41253379)
3. Werner M: Giant cell tumor of bone: morphological, biological and histogenetical aspects. Int Orthop 2006, 30:484-489
4. Fujisaki K, Tanabe N, Suzuki N, Kawato T, Takeiki O, Tsuzukibashi O, Makimura M, Ito K, Maeno M: Receptor activator of NF-kB lingand induces the expression of carbonic anhydrase II cathepsin K and metallo proteinase 9 in osteoclast percursor RAW264.7 cells. Life Sci 2007, 80:1311-1318
5. Chang SS, Suratwala SJ, Jung KM, Doppelt JD, Zhang HZ, Blaine TA, Kim TW, Winchester RJ, Lee FY: Bisphosphonates may reduce recurrence in giant cell tumor by inducing apoptosis. Clin Orthop 2004, 1:103-109
6. Anderson P, Kopp L, Anderson N, Cornelius K, Herzog C, Hughes D, Huh W: Novel bone cancer drugs: investigational agents and control paradigms for primary bone sarcomas (Ewing's sarcoma and osteosarcoma). Expert Opin Investig Drugs 2008, 17:1703-1715
7. Sawyer JR, Goosen LS, Binz RL, Swanson CM, Nicholas RW: Evidence for telomeric fusion as a mechanism for recurring structural aberrations of chromosome 11 in giant cell tumor of bone. Cancer Genet Cytogenet 2005, 159:32-36
8. Smith LT, Mayerson J, Nowak NJ, Suster D, Mohammed N, Long S, Auer H, Jones S, McKeegan C, Young G, Bos G, Plass C, Morrison C: 20q11.1 amplification in giant-cell tumor of bone: array CGH, FISH, and association with outcome. Genes Chromosomes Cancer 2006, 45:957-966
9. Wulfkuhle J, Espina V, Liotta L, Petricoin E: Genomic and proteomic technologies for individualization and improvement of cancer treatment. Eur J Cancer 2004, 40:2623-2632
10. Guenther R, Krenn V, Morawietz L, Dankof A, Melcher I, Schaser KD, Kasper HU, Kuban RJ, Ungethüm U, Sers C: Giant cell tumors of bone: molecular profiling and expression analysis of Ephrin A receptor, Claudin 7, CD52, FGFR3 and AMFR. Pathol Res Pract 2005, 201:649-663
11. Skubitz KM, Cheng EY, Clohisy DR, Thompson RC, Skubitz AP: Gene expression in giant cell tumors. J Lab Clin Med 2004, 144:193-200
12. Wuelling M, Delling G, Kaiser E: Differential gene expression in stromal cells of human giant cell tumor of bone. Virchows Arch 2004, 445:621-630 (Pubitemid 40104538)
13. Gamberi G, Benassi MS, Ragazzini P, Pazzaglia L, Ponticelli F, Ferrari C, Balladelli A, Mercuri M, Gigli M, Bretoni F, Picci P: Proteases and interleukin-6 gene analysis in 92 giant cell tumors of bone. Ann Oncol 2004, 15:498-503
14. Kawai A, Kondo T, Suehara Y, Kikuta K, Hirohashi S: Global protein-expression analysis of bone and soft tissue sarcomas. Clin Orthop Relat Res 2008, 466:2099-2106
15. Wolf RE, Enneking WF: The staging and surgery of musculoskeletal neoplasms. Orthop Clin North Am 1996, 27:473-481
16. Shevchenko A, Wilm M, Vorm O, Mann M: Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 1996, 68:850-858
17. Espina V, Dettloff KA, Cowherd S, Petricoin EF III, Liotta LA: Use of proteomic analysis to monitor responses to biological therapies. Expert Opin Biol Ther 2004, 4:83-93
18. Chen C, Gharib TG, Huang CC, Thomas DG, Shedden KA, Taylor JM, Kardia SL, Misek DE, Giordano TJ, Iannettoni MD, Orringer MB, Hanash SM, Beer DG: Proteomic analysis of lung adenocarcinoma: identification of highly expressed set of proteins in tumors. Clin Cancer Res 2002, 8:2298-2305
19. Lundgren C, Lahmann J, Becker S, Roblick U, Schedvins k, Boman k, Frankendal B, Nordström B, Auer G: 2-DE protein expression in endometrial carcinoma. Acta Oncol 2006, 45:685-694
20. Ueda S, Masutani H, Nakamura H, Tanaka T, Ueno M, Yodoi J: Redox control of cell death. Antioxid Redox Signal 2002, 4:405-414
21. Mori K, Shibanuma M, Nose K: Invasive potential induced long-term oxidative stress in mammary epithelial cells. Cancer Res 2004, 64:7464-7472
22. Sablina AA, Budanov AV, Ilyinskaya GV, Agapova LS, Kravchenko JE, Chumakov PM: The antioxidant function of p53 tumor suppressor. Nat Med 2005, 11:1306-1313 (Pubitemid 41752911)
23. Gouazè V, Mirault ME, Carpentier S, Salvayre R, Levade T, Andrieu-Abadie N: Glutathione peroxidase-1 overexpression prevents ceramide production and partially inhibits apoptosis in doxorubicintreated human breast carcinoma cells. Mol Pharmacol 2001, 60:488-496
24. Liu X, Zeng B, Ma J, Wan C: Comparative proteomic analysis of osteosarcoma cell and human primary cultured osteoblastic cell. Cancer Invest 2009, 27:345-352
25. Powis G, Montfort WR: Properties and biological activities of thioredoxins. Annu Rev Biophys Biomol Struct 2001, 30:421-455
26. Welsh SJ, Bellamy WT, Briehl MM, Powis G: The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis. Cancer Res 2002, 62:5089-5095
27. Cha MK, Suh KH, Kim IH: Overexpression of peroxiredoxin I and thioredoxin 1 in human breast carcinoma. J Exp Clin Cancer Res 2009, 28:93-104
28. Albright CD, Salganik RI, Van Dyke T: Dietary depletion of vitamin E and vitamin A inhibits mammary tumor growth and metastasis in transgenic mice. J Nutr 2004, 134:1139-1144
29. Zeisel SH: Antioxidants suppress apoptosis. J Nutr 2004, 134:3179-3180
30. Janicke RU, Sohn D, Schulze-Osthoff K: The dark side of a tumor suppressor: anti-apoptotic p53. Cell Death Differ 2008, 15:959-976
31. Cheng WH, Zheng X, Quimby FR, Roneker CA, Lei XG: Low levels of glutathione peroxidase 1 activity in selenium-deficient mouse liver affect c-Jun N-terminal kinase activation and p53 phosphorylation on Ser-15 in pro-oxidant-induced aponecrosis. Biochem J 2003, 370: 927-934
32. Laine A, Topisirovic I, Zhai D, Reed JC, Borden KLB, Ronai Z: Regulation of p53 localization and activity by Ubc13. Mol Cell Biol 2006, 26:8901-8913
33. Deininger MH, Meyermann R, Schluesener HJ: The allograft inflammatory factor-1 family proteins. FEBS Lett 2002, 514:115-121
34. Jia J, Bai Y, Fu K, Sun Z-J Chen X-M, Zhao Y-F: Expression of allograft inflammatory factor-1 and CD68 in haemangioma: implication in the progression of haemangioma. Clin Lab Invest 2008, 159:811-819
35. Autieri MV, Carbone CM: Overexpression of allograft inflammatory factor-1 promotes proliferation of vascular smooth muscle cells by cell cycle deregulation. Arterioscler Thromb Vasc Biol 2001, 21:1421-1426
36. Liu S, Tan WY, Chen QR, Chen XP, Fu K, Zhao YY, Chen ZW: Daintain AIF-1 promotes breast cancer proliferation via activation of the NF-kB/cyclin D1 pathway and facilitates tumor growth. Cancer Sci 2008, 99:952-957
37. Hunter T, Pines J: Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 1994, 79:573-582
38. Fu MF, Wang CG, Li ZP, Sakamaki T, Pestell RG: Cyclin D1: normal and abnormal functions. Endocrinology 2004, 145:5439-5447
39. Lin EY, NguYen AV, Russel RG, Pollard JW: Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 2001, 193:727-739
40. Tricot G: New insights into role of microenvironment in multiple myeloma. Lancet 2000, 355:248-250
41. Gamberi G, Serra M, Ragazzini P, Magagnoli G: Identification of markers of possible prognostic value in 57 giant cell tumors of bone. Oncol Rep 2003, 10:351-356
42. Yang ZF, Ho DW, Lau CK, Lam CT, Lum CT, Poon RT, Fan ST: Allograft inflammatory factor-1 (AIF1) is crucial for the survival and pro-inflammatory activity of macrophages. Int Immunol 2005, 17:1391-1397
43. Kamada M, So A, Muramaki M, Rocchi P, Beraldi E, Gleave M: HSP27 knockdown using nucleotide based therapies inhibit tumor growth and enhance chemotherapy in human bladder cancer cells. Mol Cancer Ther 2007, 6:299-308
44. Romani AA, Crafa P, Desenzani S, Graiani G, Lagrasta C, Siamesi M, Soliani P, Borghetti AF: The expression of HSP27 is associated with poor clinical outcome in intrahepatic cholangiocarcinoma. BMC Cancer 2007, 7:232-241
45. Takayama S, Reed JC, Homma S: Heat shock proteins as regulators of apoptosis. Oncogene 2003, 22:9041-9047
46. Mosser DD, Morimoto RI: Molecular chaperones and the stress of oncogenesis. Oncogene 2004, 23:2907-2918
47. Garrido C, Brunet M, Didelot C, Zermati Y, Schmitt E, Kroemer G: Heat shock proteins 27 and 70: antiapoptotic proteins with tumorigenic properties. Cell Cycle 2006, 5:2592-2601
48. Wang W, Eddy R, Condeelis J: The cofilin pathway in breast cancer invasion and metastasis. Nat Rev Cancer 2007, 7:429-440 (Pubitemid 46809168)
49. Vydra J, Selicharová I, Smutná K, Šanda M, Matoušková E, Buršíková E, Prchalová M, Velenská Z, David Coufal D, Jiráček J: Two-dimensional electrophoretic comparison of metastatic and non-metastatic human breast tumors using in vitro cultured epithelial cells derived from the cancer tissues. BMC Cancer 2008, 8:107-119
50. Raftopoulou M, Hall A: Cell migration: rho GTPases lead the way. Dev Biol 2004, 265:23-32 (Pubitemid 38018819)